128 related articles for article (PubMed ID: 15306964)
1. [Cost-effectivity analysis of the most used antiglaucoma drugs].
Galindo-Ferreiro A; Sánchez-Tocino H; Fernández-Muñoz M; Iglesias Cortiñas D
Arch Soc Esp Oftalmol; 2004 Aug; 79(8):379-84. PubMed ID: 15306964
[TBL] [Abstract][Full Text] [Related]
2. Medical therapy cost considerations for glaucoma.
Fiscella RG; Green A; Patuszynski DH; Wilensky J
Am J Ophthalmol; 2003 Jul; 136(1):18-25. PubMed ID: 12834665
[TBL] [Abstract][Full Text] [Related]
3. Cost analysis of glaucoma medications.
Rylander NR; Vold SD
Am J Ophthalmol; 2008 Jan; 145(1):106-13. PubMed ID: 18154755
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of monotherapy treatment of glaucoma and ocular hypertension with the lipid class of medications.
Noecker RJ; Walt JG
Am J Ophthalmol; 2006 Jan; 141(1 Suppl):S15-21. PubMed ID: 16389056
[TBL] [Abstract][Full Text] [Related]
5. Cost analysis of glaucoma medications: a 3-year review.
Vold SD; Riggs WL; Jackimiec J
J Glaucoma; 2002 Aug; 11(4):354-8. PubMed ID: 12169974
[TBL] [Abstract][Full Text] [Related]
6. Cost considerations of medical therapy for glaucoma.
Fiscella RG; Geller JL; Gryz LL; Wilensky J; Viana M
Am J Ophthalmol; 1999 Oct; 128(4):426-33. PubMed ID: 10577583
[TBL] [Abstract][Full Text] [Related]
7. A cost analysis of the prostaglandin analogs.
Mick AB; Gonzalez S; Dunbar MT; McSoley JJ
Optometry; 2002 Oct; 73(10):614-9. PubMed ID: 12408547
[TBL] [Abstract][Full Text] [Related]
8. Comparative cost evaluation of brand name and generic ophthalmology medications in Ontario.
Popovic M; Chan C; Lattanzio N; El-Defrawy S; Schlenker MB
Can J Ophthalmol; 2018 Apr; 53(2):173-187. PubMed ID: 29631831
[TBL] [Abstract][Full Text] [Related]
9. Cost analysis of glaucoma medications.
Vold SD; Wiggins DA; Jackimiec J
J Glaucoma; 2000 Apr; 9(2):150-3. PubMed ID: 10782624
[TBL] [Abstract][Full Text] [Related]
10. [Economic impact of eyedrop cost in glaucoma treatment].
Stillitano IG; Lima MG; Ribeiro MP; Cabral J; Brandt CT
Arq Bras Oftalmol; 2005; 68(1):79-84. PubMed ID: 15824808
[TBL] [Abstract][Full Text] [Related]
11. Two new drugs for glaucoma.
Med Lett Drugs Ther; 2018 Jul; 60(1551):117-120. PubMed ID: 30036347
[No Abstract] [Full Text] [Related]
12. Topical glaucoma therapy cost in Mexico.
Lazcano-Gomez G; Hernandez-Oteyza A; Iriarte-Barbosa MJ; Hernandez-Garciadiego C
Int Ophthalmol; 2014 Apr; 34(2):241-9. PubMed ID: 23846765
[TBL] [Abstract][Full Text] [Related]
13. Cost considerations in the medical management of glaucoma in the US: estimated yearly costs and cost effectiveness of bimatoprost compared with other medications.
Goldberg LD; Walt J
Pharmacoeconomics; 2006; 24(3):251-64. PubMed ID: 16519547
[TBL] [Abstract][Full Text] [Related]
14. Glaucoma medical treatment--2002: does yearly cost now equal the year?
Doyle JW; Smith MF; Tierney JW
Optom Vis Sci; 2002 Aug; 79(8):489-92. PubMed ID: 12199540
[TBL] [Abstract][Full Text] [Related]
15. Daily cost of glaucoma medications in China.
Gao Y; Wu L; Li A
J Glaucoma; 2007; 16(7):594-7. PubMed ID: 18091176
[TBL] [Abstract][Full Text] [Related]
16. Variation in Number of Doses, Bottle Volume, and Calculated Yearly Cost of Generic and Branded Latanoprost for Glaucoma.
Queen JH; Feldman RM; Lee DA
Am J Ophthalmol; 2016 Mar; 163():70-74.e1. PubMed ID: 26596398
[TBL] [Abstract][Full Text] [Related]
17. Daily cost of ophthalmic solutions for treating glaucoma in Japan.
Ikeda H; Sato E; Kitaura T; Fukuchi H; Kimura Y; Kihira K
Jpn J Ophthalmol; 2001; 45(1):99-102. PubMed ID: 11163052
[TBL] [Abstract][Full Text] [Related]
18. Estimated comparative costs of achieving a 20% reduction in intraocular pressure with bimatoprost or latanoprost in patients with glaucoma or ocular hypertension.
Fiscella R; Walt J
Drugs Aging; 2006; 23(1):39-47. PubMed ID: 16492068
[TBL] [Abstract][Full Text] [Related]
19. [Mode of action, clinical profile and significance of beta-blockers in antiglaucoma therapy].
Schlote T
Klin Monbl Augenheilkd; 2013 Feb; 230(2):120-6. PubMed ID: 23430677
[TBL] [Abstract][Full Text] [Related]
20. [Benzalkonium chloride daily dose--an important criterion in glaucoma treatment].
Výborný P; Sicáková S
Cesk Slov Oftalmol; 2011 Apr; 67(2):63-6. PubMed ID: 21751744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
